Related references
Note: Only part of the references are listed.The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Konstantin Kazankov et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy
Rui Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
Mohammad Farhad et al.
ONCOIMMUNOLOGY (2018)
Pre-natal and post-natal environment monitoring to prevent non-alcoholic fatty liver disease development
Anna Alisi et al.
JOURNAL OF HEPATOLOGY (2017)
The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
Anna Alisi et al.
MEDIATORS OF INFLAMMATION (2017)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease
Valerio Nobili et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
NAFLD and liver transplantation: Current burden and expected challenges
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2016)
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway
Guido Carpino et al.
PLOS ONE (2016)
Promising Therapy Candidates for Liver Fibrosis
Ping Wang et al.
FRONTIERS IN PHYSIOLOGY (2016)
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
Ilija Jeftic et al.
MOLECULAR MEDICINE (2015)
Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts
Sebastien Lepreux et al.
FRONTIERS IN PHYSIOLOGY (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
Wei-Chen Hsieh et al.
GUT (2015)
The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis
Emma L. Anderson et al.
PLOS ONE (2015)
M2 Kupffer Cells Promote M1 Kupffer Cell Apoptosis: A Protective Mechanism Against Alcoholic and Nonalcoholic Fatty Liver Disease
Jinghong Wan et al.
HEPATOLOGY (2014)
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Liu-cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
Nada N. Pejnovic et al.
DIABETES (2013)
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Peter G. Traber et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
Joy X. Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment
Anna Alisi et al.
ANNALS OF MEDICINE (2012)
Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis
Sheilla Andrade De Oliveira et al.
CYTOTHERAPY (2012)
Role of Galectin-3 in Classical and Alternative Macrophage Activation in the Liver following Acetaminophen Intoxication
Ana-Cristina Docan Dragomir et al.
JOURNAL OF IMMUNOLOGY (2012)
Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease
Kazuhiro Nomoto et al.
SCIENTIFIC WORLD JOURNAL (2012)
Role of Galectin-3 in Acetaminophen-Induced Hepatotoxicity and Inflammatory Mediator Production
Ana-Cristina Dragomir et al.
TOXICOLOGICAL SCIENCES (2012)
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Carla Iacobini et al.
JOURNAL OF HEPATOLOGY (2011)
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Dina G. Tiniakos et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD-Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network
Elizabeth M. Brunt et al.
HEPATOLOGY (2009)
Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3-/- mice
F. L. Oliveira et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice
K. Nomoto et al.
JOURNAL OF PATHOLOGY (2006)
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)
E. Cacciari et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
